【正文】
Influence ofthe number and concentration of progenitor cells[ J]. BoneJointSurgAm, 2005, 87(7): 1430.[12] Ph Hernigou G,Mathieu,H. Rouard. Percutaneous Autologous BoneMarrow Grafting for Nonunions. Surgical Technique[J]. J Bone JointSurgAm, 2006, 88: 322327.[13] Tauchmanova L, Colao A,Gaetano LombardiG, et Boneloss and itsmanagement in longterm survivors from allogeneic sterm cell transplantation[ J]. Clin EndocrinoMetab,2007, 92(12): 45364545.[14]曹誼林,周廣東,劉偉,[J].中華創(chuàng)傷雜志, 2005, 21(1): 2528.[15] ,Frank P. Cammisa, Jr,Harvinder S. Biology of Bone Graftin. J. Am. Acad[J]. Ortho. Surg,Jan,2005,13:77.[16] Einhorn TA. Clinical applications of rebinant humanBMPs: early experience and future development[J]. J BoneJointSurgAm, 2003, 85A(3).[17] Alan L. Jones, Sohail BMP2 and Allograft Compared with Autogenous Bone Graft for Reconstruction of Diaphyseal TibialFractures with Cortical Defects. A Randomized, ControlledTrial[J].Bone SurgAm, 2006, 88: 14311441.[18] G. Burastero, G. Grappiolo,M Podesta. EFFICACY OF HMSC+BPM7 IN BONE GRAFT[J]. J Bone Joint Surg BrProceedings, 2006, 88B: 33.[19] Groeneveld EH, proteins inhuman bone regeneration[ J]. Eur J Endocrino,l 2000, 142(1): 921.